Whalatane, I don't think you are in disagreement with me. What I am saying is that at this point in time, few docs are going to prescribe Vascepa to patients for any reason other than the fact that their patient has high tg. Yes, science may show it has benefits well beyond lowering tg but docs aren't going to prescribe it for that reason. In fact, Anchor won't even approve it for that reason as far as I know
Market Data 
Markets 
AI
